期刊文献+

炎症诱导性表达载体的表达特性 被引量:1

Character of inducible expression vector for excessive inflammatory response
下载PDF
导出
摘要 目的 :构建一种具有自控性的炎症诱导性表达载体 ,为探索符合临床实际的抗炎基因治疗新系统奠定基础。 方法 :(1)将对炎症敏感的 SAA3启动子调控片段与报告基因 CAT片段重组 ,构建炎症诱导性表达载体 p SAA3/CAT;(2 )用脂质体转染法将表达载体 p SAA3/CAT转入体外培养细胞或动物体内 ,观察不同时间、不同剂量的炎性刺激时报告基因的表达变化 ,分析 SAA3启动子体内外转录活性和炎症诱导性。 结果 :(1)阳离子脂质体包裹表达质粒可以有效地转染肝源性细胞SMMC- 772 1和单核细胞源性细胞 U937,经活化后的 U 937细胞可迅速表达 CAT,6 h启动 ,2 4 h达峰值 ,72 h渐降至基础水平。(2 )腹腔注射脂质体包裹 DNA可有效转染外源报告基因 CAT在体内表达 ;L PS活化的基因转染小鼠肝脏中的 CAT表达与一次典型的急性反应时间一致 ,鼠肝 CAT表达水平与 L PS有显著的剂量依赖关系。 结论 :初步建立了一种具有自控性的有效抗炎基因治疗新系统。 Objective:To construct inducible expression vector for excessive inflammatory response with autocontrol, providing a new anti inflammatory genetherapy for clinical excessive inflammatory response. Methods:(1) Recombining SAA3 promoter and report gene CAT to construct inducible expression vector pSAA3/CAT. (2) Transfecting cells in vitro or animal in vivo by the mixture of pSAA3/CAT and liposome to observe expression character of report gene CAT under different inflammatory stimulators, and the transcription character of SAA3 promoter was analyzed. Results: (1) The mixture of pSAA3/CAT and liposome effectively transfected SMMC 7721 and U937 cells. Activated U937 cells expressed CAT rapidly. CAT expression was detected 6 h after LPS activation and peaked after 24 h, decreased after 72 h in U937 cells. (2) Mouse transfected with PSAA3/CAT3 lipsome mixture (ip) and LPS (ip) induced CAT reporter gene expression in liver and lung. The expression of CAT in transfected mouse was in accordance with a typical acute response, hepatic CAT expression was in proportion to the LPS doses. Conclusion:An effective strategy of anti inflammatory genetherapy with autocontrol is set up.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2002年第6期648-651,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金资助项目 (3 990 0 14 0 )
关键词 炎症 诱导性表达载体 基因疗法 淀粉样蛋白 SAA 脓态症 inflammation gene therapy amyloid protein SAA
  • 相关文献

参考文献8

  • 1[1]Oberholzer C,Oberholzer A,Bahjat FR,et al.Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis[J].Proc Natl Acad Sci USA,2001,98(20):11503-11508.
  • 2[2]Abraham E,Anzueto A,Gutierrez G,et al.Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock.NORASEPT II Study Group[J].Lancet,1998,351(9107):929-933.
  • 3[3]Litzinger DC,Brown JM,Wala I,et al.Fate of cationic liposomes and their complex with oligonucleotide in vivo[J].Biochim Biophys Acta,1996,1281(2):139-149.
  • 4[4]Liu F,Liu D.Serum independent liposome uptake by mouse liver[J].Biochim Biophys Acta,1996,1278(1):5-11.
  • 5[5]Stuber F. Effects of genomic polymorphisms on the course of sepsis:is there a concept for gene therapy[J]? J Am Soc Nephrol,2001,12(17):S60-S64.
  • 6[6]Chen GH,Reddy RC,Newstead MW,et al.Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense[J].J Immunol,2000,165(11):6496-6503.
  • 7[7]Ebersole JL,Cappelli D.Acute-phase reactants in infections and inflammatory diseases[J].Periodontol,2000,23(1):19-49.
  • 8[8]Rygg M,Husby G,Marhaug G,et al.Differential expression of rabbit serum amyloid A genes in response to various inflammatory agents[J].Scand J Immunol,1993,38(5):417-422.

同被引文献19

  • 1Wang Y D, Chen W D, Wang M,Yu D,Forman B M, Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response [ J ]. Hepatology, 2008, 48: 1632-1643.
  • 2Kanesaka S, Sasaki J, Kuzume M, Narihara K, Takahashi Y. Effect of direct hemoperfusion using polymyxin B immobilized fiber on inflammatory mediators in patients with severe sepsis and septic shock[J]. Int J ArtifOrgans,2008,31:891-897.
  • 3Castelli G P,Pognani C,Meisner M,Stuani A,Bellomi D,Sgarbi L. Proealeitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction [J]. Crit Care, 2004,8:R234-R242.
  • 4Aoki T, Kataoka H, Shimamura M, Nakagami H, Wakayama K,Moriwaki T,et al. NF-kappaB is a key mediator of cerebral aneurysm formation[J]. Circulation, 2007,116: 2830-2840.
  • 5Takahashi H,Tsuda Y, Takeuchi D, Kobayashi M, Herndon D N,Suzuki F. Influence of systemic inflammatory response syndrome on host resistance against bacterial infections[J]. Crit Care Med,2004,32 : 1879-1885.
  • 6Turunen P, Puhakka H L, Heikura T, Romppanen E, Inkala M, Leppanen O, et al. Extracellular superoxide dismutase with vaccinia virus anti-inflammatory protein 35K or tissue inhibitor of metalloproteinase-1 : Combination gene therapy in the treatment of vein graft stenosis in rabbits[J]. Hum Gene Ther, 2006,17 : 405-414.
  • 7Griga T, Wilkens C, Schmiegel W, Folwaezny C, H agedorn M, Duerig N, et al. Association between the promoter polymorphism T/C at position-159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease [J]. Eur J Med Res,2005,10:183-186.
  • 8Ivanenkov Y A,Balakin K V,Tkachenko S E. New approaches to the treatment of inflammatory disease:focus on small-molecule inhibitors of signal transduction pathways[J]. Drugs R D, 2008,9: 397-434.
  • 9Elsharkawy A M, Mann D A. Nuclear factor kappaB and the hepatic inflammation-fibrosis-cancer axis[ J ]. Hepatology, 2007,46 : 590-597.
  • 10Matek R, Borowicz K K,Jargiello M,Czuczwar S J. Role of nuclear factor kappaB in the central nervous system[J]. Pharmacol Rep, 2007,59 : 25-33.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部